Abstract
This article reviews the structures and biological activities of several classes of uridine-containing nucleoside antibiotics (tunicamycins, mureidomycins/pacidamycins/sansanmycins, liposidomycins/caprazamycins, muraymycins, capuramycins) that target translocase MraY on the peptidoglycan biosynthetic pathway. In particular, recent advances in structure-function studies, and recent X-ray crystal structures of translocase MraY complexed with muraymycin D2 and tunicamycin are described. The inhibition of other phospho-nucleotide transferase enzymes related to MraY by nucleoside antibiotics and analogues is also reviewed.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Anti-Bacterial Agents / chemistry*
-
Anti-Bacterial Agents / pharmacology*
-
Bacterial Proteins / antagonists & inhibitors
-
Bacterial Proteins / metabolism
-
Biological Products / chemistry*
-
Biological Products / pharmacology*
-
Nucleosides / chemistry
-
Nucleosides / pharmacology*
-
Peptidoglycan / metabolism
-
Transferases (Other Substituted Phosphate Groups)
-
Transferases / antagonists & inhibitors
-
Transferases / metabolism
-
Uridine / analogs & derivatives
-
Uridine / chemistry
Substances
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
Biological Products
-
Nucleosides
-
Peptidoglycan
-
Transferases
-
Transferases (Other Substituted Phosphate Groups)
-
mraY protein, Bacteria
-
Uridine